EPP is caused by an inherited loss-of-function mutation in the gene for the final enzyme of heme biosynthesis, Ferrochelatase (FECH), whereas XLP patients carry gain-of-function pathogenic variants in erythroid-specific ALAS2, which encodes the first enzyme of heme synthesis. This evidence concerns the gene FECH and X-linked lymphoproliferative disease.